The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so i i some of the most clinically studied for safety efficacy would be viz biome which is uh vsl3 um it's it's now rebranded as this biome um mutaflor is an actually a beneficial strain of e coli that might uh basically out-compete those more negative facultative anaerobes in the gut
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.